Documente Academic
Documente Profesional
Documente Cultură
Team Tan
Agenda
01 Perceptions and Policies
02 Long-term Implications
03 #GoBoldly
Recommendations &
04 Implementation
Perception Leads to Policy
Presentation
“FDA Commissioner Scott Gottlieb says the agency is concerned with certain drugmakers' tactics
designed to instill fear in patients and doctors about switching from originator biologics to biosimilars.”
Future Projections of US Pharma Market
2019 2020 2021 2022 2023 2024
US Market Share** 347.6 361.5 376 391 406.6 423 Net Present
Value of US
Profit*** 68.5 71.2 74 77 80 83.3 Profits:
$371B
Present Value**** 64 65.6 61.5 60 58.7 61
*Revenue Forecast: Sum of top 23 Pharma Companies 2017 Revenues (from financial statements) with a conservative growth rate of 4% CAGR.
**US Market Share: Approximation of 45.1% of US share of total global Pharma sales based on OECD Report:
OECD., et al. Pharmaceutical pricing policies in a global market. 2008.
***Profit forecast: Average weighted forecast of profits of top 5 US Pharma companies from 2015-2017 (see 10k Financial Statements)
****Discount Rate: Weighted Average Cost of Capital of top 5 US Pharma companies
Policy Impact on US Revenue
450
400
350
300
US Revenue
(billions)
250
200
150
100
50
0
2019 2020 2021 2022 2023 2024
*Rand Corp estimation of 20.3% reduction of revenue in the US Pharma industry given Price Control regulation:
Sood, N., De Vries, H., Gutierrez, I., Lakdawalla, D. N., & Goldman, D. P. (2009). The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Affairs, 28(1), w125-
w137.
Policy Impact on US Profits
400
150
100
50
0
No Regulation Regulation
Long-term Implications of Policy
Less Incentive
Profits Suffer to Innovate
Decrease in Negative
Life Impact on
Expectancy Labor Force
#GoBoldly Campaign
*Source: “Rebranding Pharma” Kellogg School of Management Case Study, Tim Calkins, 2019
Sources: https://innovation.org/
https://www.youtube.com/watch?v=rzLQfUngldk
https://www.phrma.org/press-release/america-s-biopharmaceutical-companies-launch-groundbreaking-multi-year-initiative-heralding-new-era-of-medicine
*Source: Gallup Poll 2018: https://news.gallup.com/poll/12748/business-industry-sector-ratings.aspx
Our Findings…
Before After %
Daunting perceptions of
“science” Distrust of scientists
Optimize channels
Impactful Stories What’s -Broadcast efficiency
-Patient profiles Positive Missing Outreach -Refocus target audience
-Researcher profiles Stories -Social media & digital presence
-Patient/Researcher stories Already optimization
-Community programs
Have
2. #KnowYourDrug Campaign
Current #GoBoldly Digital Media Outreach
YouTube
0.3k – 400k views per video 30k – 700k views per video
Increasing Importance
of Digital Media
• Continuous decline in TV consumption
• Increasing streaming service subscriptions for media and
entertainment, especially for young adults
• One-third of young adults receive news and information
digitally
Additional Marketing Efforts
2. #KnowYourDrug Campaign
#KnowYourDrug
Be More Accountable
1 Acknowledge setbacks and show progress
Be More Transparent
2 More direct information reduces speculation
Be Bold
4 Face the controversies head on
Thank you!
Team Tan